Secondary Hyperparathyroidism

Parathyroid Gland Size May Affect Cinacalcet Response

Jody A. Charnow January 15, 2010

Parathyroid gland enlargement may delay the response of secondary hyperparathyroidism to cinacalcet, Japanese researchers reported in Nephron Clinical Practice (2009; published online ahead of print).
 

Researchers Link Elevated PTH to High Uric Acid

Eric Butterman November 01, 2009

Elevated serum parathyroid hormone levels are associated with higher serum uric acid levels in the U.S. adult population, investigators reported at ASN's Renal Week 2009.
 

Specialty Pharmacy Improves Control of Secondary Hyperparathyroidism

Eric Butterman November 01, 2009

Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis patients, researchers reported at ASN's Renal Week 2009.
 

Cinacalcet Safely Treats Persistent Post-Kidney-Transplant Hyperparathyroidism

Eric Butterman November 01, 2009

Cinacalcet therapy is safe and effective for treating persistent hyperparathyroidism after renal transplantation, British researchers reported at ASN's Renal Week 2009. The medication is not associated with allograft dysfunction or significant adverse effects.
 

Elevated Parathyroid Hormone Linked to Obesity in CKD Patients

Eric Butterman November 01, 2009

Obesity in CKD patients is associated with increased parathyroid hormone levels independent of estimated glomerular filtration rate, according to a study presented at ASN's Renal Week 2009.
 

PTH Response to Calcitriol Reduced in African-American CKD Patients

Eric Butterman October 31, 2009

Among patients with stages III-IV CKD, African-American race is associated with a decreased parathyroid hormone response to oral calcitriol, according to a study presented at ASN's Renal Week 2009.
 

Loop Diuretics Raise Risk of Secondary Hyperparathyroidism

Eric Butterman October 31, 2009

Loop diuretics increase the risk of secondary hyperparathyroidism in CKD patients, but concurrent use of thiazide diuretics attenuate that risk, data suggest according to a study that was presented at ASN's Renal Week 2009.
 

Cinacalcet Effective for Refractory Hyperparathyroidism

Eric Butterman October 31, 2009

Cinacalcet showed long-term efficacy in reducing serum parathyroid hormone and calcium levels in renal transplant patients with refractory tertiary hyperparathyroidism, according to a study presented at ASN's Renal Week 2009.
 

Vitamin D Insufficiency Common in Dialysis Patients with Secondary Hyperparathyroidism

Jody A. Charnow October 30, 2009

Nutritional vitamin D deficiency is widespread among hemodialysis patients with secondary hyperparathyroidism, and few receive nutritional vitamin D supplementation, according to a study presented at Renal Week 2009.
 

High iPTH Levels Increase the Risk of Death, Need for Renal Replacement Therapy

Jody A. Charnow October 30, 2009

Intact parathyroid hormone levels higher than 50 pg/mL in patients with stage 3 or 4 CKD are associated with an increased risk of death or the need for renal replacement therapy, data show according to a study presented at ASN's Renal Week 2009.
 

NKF Live Promotion

Enter a contest to win one of three $150 American Express gift cards by signing up for the free NKF Live e-newsletter. You will receive daily news coverage of the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla.

Click here to sign up today



Visit Fresenius Medical Care during the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla. at Booth #407.
Visit our Conference Highlights section for news from recent meetings, including our coverage of the 2010 Genitourinary Cancers Symposium.

Job Search